Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
Authors
Keywords
-
Journal
BMJ-British Medical Journal
Volume -, Issue -, Pages e071249
Publisher
BMJ
Online
2022-07-21
DOI
10.1136/bmj-2022-071249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines
- (2022) Rebecca Kahn et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
- (2022) Peter Nordström et al. LANCET
- Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
- (2022) Hung Fu Tseng et al. NATURE MEDICINE
- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina
- (2022) Dan-Yu Lin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada
- (2022) Danuta M Skowronski et al. CLINICAL INFECTIOUS DISEASES
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
- (2022) Daniel R Feikin et al. LANCET
- Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
- (2022) Adam S Lauring et al. BMJ-British Medical Journal
- Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
- (2021) Joseph A. Lewnard et al. EPIDEMIOLOGY
- Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
- (2021) Emma Pritchard et al. NATURE MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Vaccine Effectiveness and the Test-Negative Design
- (2021) Natalie E. Dean et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil
- (2021) Srinivasa Vittal Katikireddi et al. LANCET
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- (2021) Sara Y Tartof et al. LANCET
- Waning Immunity after the BNT162b2 Vaccine in Israel
- (2021) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Vaccine Effectiveness in New York State
- (2021) Eli S. Rosenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
- (2021) Einav G. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
- (2021) Katia J Bruxvoort et al. BMJ-British Medical Journal
- Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination
- (2021) Chris Davis et al. PLoS Pathogens
- Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
- (2021) Deborah Cromer et al. Lancet Microbe
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness
- (2016) Sheena G. Sullivan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Invited Commentary: Beware the Test-Negative Design
- (2016) Daniel Westreich et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now